DK0940386T3 - Benzocyklobutanforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne forbindelser - Google Patents

Benzocyklobutanforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne forbindelser

Info

Publication number
DK0940386T3
DK0940386T3 DK99400506T DK99400506T DK0940386T3 DK 0940386 T3 DK0940386 T3 DK 0940386T3 DK 99400506 T DK99400506 T DK 99400506T DK 99400506 T DK99400506 T DK 99400506T DK 0940386 T3 DK0940386 T3 DK 0940386T3
Authority
DK
Denmark
Prior art keywords
compounds
alkyl
benzocyclobutane
preparation
methods
Prior art date
Application number
DK99400506T
Other languages
Danish (da)
English (en)
Inventor
Jean-Louis Peglion
Aimee Dessinges
Jean-Christophe Harmange
Mark Millan
Adrian Newman-Tancredi
Mauricette Brocco
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0940386T3 publication Critical patent/DK0940386T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/48Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
DK99400506T 1998-03-04 1999-03-03 Benzocyklobutanforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne forbindelser DK0940386T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9802585A FR2775687B1 (fr) 1998-03-04 1998-03-04 Nouveaux composes du benzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0940386T3 true DK0940386T3 (da) 2002-09-16

Family

ID=9523607

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99400506T DK0940386T3 (da) 1998-03-04 1999-03-03 Benzocyklobutanforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne forbindelser

Country Status (19)

Country Link
US (1) US6107345A (de)
EP (1) EP0940386B1 (de)
JP (1) JP3676110B2 (de)
CN (1) CN1137083C (de)
AT (1) ATE217861T1 (de)
AU (1) AU745808B2 (de)
BR (1) BR9900850A (de)
CA (1) CA2264372C (de)
DE (1) DE69901522T2 (de)
DK (1) DK0940386T3 (de)
ES (1) ES2178357T3 (de)
FR (1) FR2775687B1 (de)
HK (1) HK1021895A1 (de)
HU (1) HU224310B1 (de)
NO (1) NO312096B1 (de)
NZ (1) NZ334447A (de)
PL (1) PL331729A1 (de)
PT (1) PT940386E (de)
ZA (1) ZA991748B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2807753B1 (fr) * 2000-04-13 2002-06-07 Adir Nouveaux derives d'heterocycloalkylbenzocyclobutane et d'heteroarylbenzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN102264689B (zh) * 2008-12-22 2014-12-31 新梅斯托克尔卡公司 制备伊伐布雷定的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214055A (en) * 1990-05-18 1993-05-25 Adir Et Compagnie Aminopiperidine 4-oxo-4H-chromen-2-yl compounds
FR2662162B1 (fr) * 1990-05-18 1995-01-20 Adir Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
ES2178357T3 (es) 2002-12-16
CA2264372A1 (fr) 1999-09-04
JP3676110B2 (ja) 2005-07-27
FR2775687A1 (fr) 1999-09-10
AU745808B2 (en) 2002-04-11
JPH11310557A (ja) 1999-11-09
NO991043L (no) 1999-09-06
EP0940386A1 (de) 1999-09-08
DE69901522T2 (de) 2003-01-09
EP0940386B1 (de) 2002-05-22
NZ334447A (en) 2000-01-28
FR2775687B1 (fr) 2000-04-14
HK1021895A1 (en) 2000-07-14
NO312096B1 (no) 2002-03-18
HU9900519D0 (en) 1999-04-28
BR9900850A (pt) 2000-05-02
NO991043D0 (no) 1999-03-03
DE69901522D1 (de) 2002-06-27
US6107345A (en) 2000-08-22
PT940386E (pt) 2002-09-30
CN1137083C (zh) 2004-02-04
PL331729A1 (en) 1999-09-13
HUP9900519A1 (hu) 2000-08-28
CA2264372C (fr) 2003-07-08
ZA991748B (en) 1999-09-16
ATE217861T1 (de) 2002-06-15
CN1228414A (zh) 1999-09-15
AU1861899A (en) 2000-06-08
HU224310B1 (hu) 2005-07-28

Similar Documents

Publication Publication Date Title
ATE268603T1 (de) Zubereitung, enthaltend lipoproteine und crotonsäureamidderivate
NZ238181A (en) N-(1-substituted-piperidinyl(alkyl))carbamic acid, urea and carboxamide derivatives and homologues thereof; preparatory processes and pharmaceutical compositions
DE50009239D1 (de) Stabile salze neuartiger derivate von 3,3-diphenylpropylaminen
EA200401056A1 (ru) Комбинация, содержащая производные тропана, полезные в терапии
TR199800628T2 (xx) 8-Azabisiklo$3.2.1]okt-2-en t�revleri, bunlar�n haz�rlanmas� ve kullan�m�.
IL108695A (en) Pharmaceutical composition comprising polyamine derivatives and some such novel compounds
CA2251003A1 (fr) Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
DK0940386T3 (da) Benzocyklobutanforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne forbindelser
DE59607208D1 (de) Verwendung eines Natrium- oder Lysiniumsalzes von Crotonsäureamidderivaten zur Herstellung eines Arzneimittels zur Behandlung von Krebserkrankungen
FI970446A0 (fi) Urokinaasireseptorin ligandeja
ATE262901T1 (de) Verwendung von isoxazol- und crotonsäureamidderivaten zur modulation der apoptose
DK0541263T3 (da) 5-Piperazinylalkyl-1,5-benzothiazepinoner, der er nyttige som calciumantagonister
NO972943L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende dem og deres anvendelse
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
AR029375A1 (es) DERIVADOS DE CARBOXAMIDA, UN PROCEDIMIENTO PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACEUTICA QUE LOS COMPRENDE Y EL USO DE DICHO DERIVADO PARA LA FABRICACION DE UN MEDICAMENTO
PT1038863E (pt) Novos derivados dimericos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem
BR9709074A (pt) Derivados de polihidroxifenol agentes de prevencão e terapéuticos para doencas ósseas e de cartilagem contendo os mesmos
NO981566L (no) Nye aminoforbindelser av 6,7,8,9-tetrahydro-cyklopenta[a]naftalen og av 2,3-dihydro-cyklopenta[e]inden, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger som inneholder dem
RU2369605C2 (ru) Производные диарилмочевины, применяемые для лечения зависимых от протеинкиназ болезней
NO972942D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse